Aced it again in your blog, Claude.
Do you feel like flicking off an email to John Sharman with the comment made by the ambo to your blog about measured doses, and asking if this is a step MVP is taking to enhance Penthrox?
Ann: MVP announces FDA Approval , page-4
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.24M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 334 | 1 |
View Market Depth
| Last trade - 09.57am 31/07/2024 (20 minute delay) ? |
| MVP (ASX) Chart |
Day chart unavailable